Careclub – potency remedy | Buy in Ukraine with delivery

What is Careclub?

Careclub is a medicinal product belonging to the group of agents affecting the functional state of the cardiovascular system and metabolic processes in the myocardium. The drug was developed by the pharmaceutical company Careclub, which specializes in creating modern cardiology and metabolic agents with proven clinical efficacy. The release form of CARECLUB is hard gelatin capsules for oral use, which ensures convenient dosing and high bioavailability of active components. According to its pharmacological action, the drug belongs to metabolic agents that improve energy metabolism in heart muscle cells and contribute to the restoration of ischemic tissues. The main purpose of CARECLUB is the comprehensive support of heart function under conditions of increased stress, chronic ischemia, or impaired metabolic processes in cardiomyocytes.

The pharmacological group of CARECLUB encompasses cardioprotective and antianginal agents, which allows the drug to be used both as part of combination therapy and as monotherapy in the early stages of metabolic disorders of the heart. The manufacturer Careclub pays special attention to the standardization of raw materials and multi-stage quality control at every stage of the manufacturing cycle. The drug is produced in blisters, which guarantees protection from moisture and light, as well as convenience of home storage. Clinical studies have confirmed that the active components of CARECLUB have the ability to accumulate in myocardial tissues, providing a prolonged therapeutic effect. Thanks to the optimal ratio of active substances, the drug demonstrates a favorable safety profile and good tolerability in patients of various age groups.

CARECLUB is positioned as a means for restoring the energy potential of the heart muscle, which is especially relevant for patients with chronic forms of ischemic heart disease, post-infarction cardiosclerosis, and myocardial dystrophic changes. The drug is not a hormonal agent and does not contain components that cause addiction or withdrawal syndrome. It is important to understand that CARECLUB does not replace basic therapy for acute cardiovascular conditions, but is used as an adjuvant to improve the metabolic background. The prescription of the drug should be made by a physician after evaluating the clinical picture, electrocardiogram results, and laboratory parameters. Self-treatment of cardiological pathologies is unacceptable, as it can lead to the progression of the underlying disease and the development of complications.

What is Careclub prescribed for?

CARECLUB is prescribed to patients with chronic ischemic heart disease to reduce the frequency of angina attacks and improve exercise tolerance. The drug contributes to the optimization of energy metabolism under conditions of insufficient oxygen supply to the myocardium, which allows for reducing the severity of anginal pain and shortness of breath. Due to its cardioprotective effect, CARECLUB helps maintain the functional activity of the heart muscle even in the presence of atherosclerotic changes in the coronary arteries. The clinical effect develops gradually, so the drug is recommended for course administration with regular monitoring of the patient's condition.

The second important area of application for CARECLUB is rehabilitation after myocardial infarction and cardiac surgery. During this period, the heart muscle requires enhanced metabolic support to restore contractile function and prevent left ventricular remodeling. The active components of the drug stimulate the synthesis of high-energy compounds, which accelerates repair processes in damaged areas of the myocardium. CARECLUB is also included in the complex therapy of myocardial dystrophy caused by chronic stress, hormonal disorders, or long-term administration of cardiotoxic drugs. In such cases, the drug helps restore the normal structure of cardiomyocytes and improve their resistance to adverse factors.

CARECLUB can be recommended to patients with cardiac arrhythmias of metabolic origin, particularly extrasystole and sinus tachycardia occurring against the background of autonomic dysfunction. The drug helps stabilize cell membranes and normalize electrolyte balance, which positively affects the conduction system of the heart. In addition, CARECLUB is used in preventive programs for individuals at high risk of developing cardiovascular diseases, particularly in the presence of arterial hypertension, diabetes mellitus, or obesity. In each specific case, the appropriateness of prescribing the drug is determined by a physician, taking into account the individual characteristics of the patient and concomitant pathology.

Composition and active components of Careclub

CARECLUB contains carefully selected active components that provide a complex effect on metabolic processes in the heart muscle. The main active substance is trimetazidine dihydrochloride — an antianginal agent that blocks the oxidation of fatty acids in cardiomyocytes and switches energy metabolism to a more efficient utilization of glucose. Such a mechanism of action allows maintaining an adequate level of adenosine triphosphate even under conditions of limited oxygen supply, which is especially important in myocardial ischemia. Trimetazidine also reduces intracellular acidosis and prevents the accumulation of calcium ions, which can damage cell membranes.

An additional active component of CARECLUB is magnesium orotate — a compound combining the trace element magnesium and orotic acid, which is a precursor of pyrimidine nucleotides. Magnesium plays a key role in regulating neuromuscular conduction, maintaining normal heart rhythm, and preventing coronary vessel spasms. Orotic acid stimulates the synthesis of nucleic acids and proteins in cardiomyocytes, contributing to the recovery of damaged cell structures. The combination of trimetazidine and magnesium orotate provides a synergistic effect, enhancing the cardioprotective action of each component individually. The excipients included in the capsule ensure the stability of the drug and optimal release of active components in the gastrointestinal tract.

The mechanism of action of CARECLUB is based on the ability of active substances to influence key links of energy metabolism in cardiomyocytes, protecting them from the consequences of hypoxia. The drug reduces the myocardium's oxygen demand without affecting heart rate and blood pressure, which favorably distinguishes it from traditional antianginal agents. CARECLUB also exerts a membrane-stabilizing effect, preventing the destruction of cell membranes under the action of free radicals and lipid peroxidation products. Thanks to such a multifaceted effect, the drug not only eliminates the symptoms of ischemia, but also affects the pathogenetic mechanisms of the development of metabolic disorders in the heart muscle.

Careclub dosage

The standard therapeutic dose of CARECLUB for adult patients is one capsule three times daily during meals. This dosage regimen provides a uniform intake of active components into the body throughout the day and maintains a stable therapeutic concentration in blood plasma. The maximum daily dose should not exceed three capsules, as increasing the dosage does not lead to an increased therapeutic effect, but may increase the risk of side effects. The duration of the treatment course with CARECLUB is determined individually depending on the nature of the disease, the severity of clinical manifestations, and the patient's response to therapy, but usually ranges from one to three months.

For elderly patients, dose adjustment of CARECLUB is usually not required, but more careful monitoring of renal and hepatic function is recommended throughout the treatment period. Patients with moderate renal impairment may be recommended to increase the interval between doses or reduce the daily dose, as determined by a physician based on creatinine clearance parameters. If a regular dose of CARECLUB is missed, a double dose should not be taken to compensate, as this may cause excessive stress on the body. The next capsule should be taken at the usual time, adhering to the established schedule.

The duration of continuous use of CARECLUB is usually limited to three months, after which the doctor evaluates the appropriateness of continuing therapy or prescribing a repeated course after a break. In the absence of clinical improvement during the first two to three weeks of treatment, it is necessary to review the diagnosis and therapy scheme. Self-increasing the dose or extending the treatment course with CARECLUB without consulting a doctor is unacceptable and can lead to undesirable consequences. The drug is intended exclusively for use in adult patients; experience of use in pediatric practice is absent.

How to take Careclub properly?

CARECLUB should be taken during or immediately after meals, swallowed with a sufficient amount of water, which ensures optimal absorption of active components and reduces the risk of irritation of the gastric mucosa. The capsule must be swallowed whole, without chewing or opening, as violating the integrity of the shell may alter the pharmacokinetic properties of the drug. It is recommended to observe equal intervals between doses, dividing the daily dose into three doses throughout the day. This approach allows maintaining a stable concentration of active substances in the blood and providing a continuous therapeutic effect.

If a patient forgot to take CARECLUB at the specified time, it should be done as soon as possible, provided there are at least four hours left before the next dose. If the next dose is already close, the missed dose should be skipped and the regular schedule resumed to avoid double dosing. During treatment with CARECLUB, it is important to follow lifestyle recommendations, including avoiding excessive physical exertion, stressful situations, and harmful habits. The drug is not intended for the relief of acute angina attacks, so if sudden chest pain occurs, fast-acting nitrates prescribed by a doctor should be used.

To achieve the maximum therapeutic effect, CARECLUB is recommended to be taken regularly, without missing doses, even if subjective well-being improved earlier than expected. Abrupt discontinuation of the drug does not cause withdrawal syndrome, but may lead to a gradual return of symptoms of the underlying disease. Patients taking CARECLUB should regularly undergo follow-up examinations, including electrocardiography and laboratory tests, to evaluate the efficacy and safety of therapy. Any changes in the dosage regimen or duration of the course must be agreed upon with a physician.

Side effects of Careclub

CARECLUB is generally well tolerated by patients, but in some cases, the development of side effects is possible, which are divided into common, uncommon, and rare according to the frequency of occurrence. Common side effects include dyspeptic phenomena such as nausea, a feeling of heaviness in the epigastric region, loss of appetite, and flatulence. These symptoms are usually transient in nature and disappear on their own after a few days of taking the drug without the need to discontinue therapy. In patients with hypersensitivity to the components of CARECLUB, headaches, dizziness, and general weakness may be observed, requiring monitoring of condition dynamics.

Uncommon side effects of CARECLUB include allergic manifestations in the form of skin rash, itching, urticaria, or angioedema. In rare cases, orthostatic hypotension accompanied by dizziness during a sharp change in body position may occur. Patients with impaired renal function may experience increased fatigue and muscle weakness, which is associated with the accumulation of magnesium in the body. Rare side effects include cardiac arrhythmias, limb tremors, confusion, and severe allergic reactions requiring immediate medical attention.

If any unusual symptoms appear while taking CARECLUB, the patient should consult a doctor to evaluate their association with the drug and determine further tactics. Special attention is required in cases of shortness of breath, edema of the lower extremities, impaired consciousness, or severe allergic reactions, which may indicate serious complications. The individual reaction of the body to CARECLUB may vary depending on age, health status, the presence of concomitant diseases, and genetic characteristics of the patient. If side effects not specified in the instructions occur, it is necessary to report them to a doctor or pharmacist.

Contraindications of Careclub

CARECLUB has a number of absolute contraindications, in the presence of which the use of the drug is strictly forbidden. These include increased individual sensitivity to trimetazidine, magnesium orotate, or any auxiliary components of the drug, which may manifest as allergic reactions of varying severity. The drug is not prescribed to patients with severe renal insufficiency, as impaired magnesium excretion can lead to the development of hypermagnesemia with dangerous consequences for the cardiovascular and nervous systems. CARECLUB is contraindicated in severe hepatic impairment, cirrhosis, and acute hepatitis, as the metabolism of active components occurs precisely in the liver.

Relative contraindications of CARECLUB include conditions in which the drug can be prescribed only with special caution and under close medical supervision. This applies to patients with moderate renal impairment, arterial hypotension, bradycardia, and cardiac conduction disorders. The use of CARECLUB during pregnancy is not recommended, as there are insufficient data on the safety of the drug for the fetus. During breastfeeding, taking the drug should also be avoided or breastfeeding should be temporarily discontinued during treatment, as active components can penetrate into breast milk.

CARECLUB is not used in pediatric practice due to the lack of clinical data on the efficacy and safety of the drug in children under 18 years of age. For elderly patients, the drug is prescribed with caution, taking into account the possible age-related decline in renal and hepatic function. Before starting CARECLUB therapy, the physician must carefully collect a medical history, assess the functional state of organs and systems, and rule out contraindications. Patients with rare hereditary diseases associated with metabolic disorders may require additional examination before prescribing the drug.

Interaction of Careclub with other drugs and alcohol

CARECLUB may interact with other medicinal products, so before starting therapy, it is necessary to inform the doctor about all drugs the patient is taking on a permanent or temporary basis. Concomitant use of CARECLUB with antihypertensive agents, particularly beta-blockers and calcium channel blockers, may enhance their effect on blood pressure and heart rate, requiring dose adjustment. The drug is not recommended to be combined with other magnesium-containing agents, as this increases the risk of hypermagnesemia, especially in patients with impaired renal function. CARECLUB may reduce the efficacy of certain tetracycline antibiotics and iron supplements, so an interval of at least two to three hours should be observed between their intake.

Alcohol consumption during CARECLUB treatment is not recommended, as ethanol can increase the toxic load on the liver and negate the therapeutic effect of the drug. Alcohol is also capable of provoking heart rhythm disturbances and increasing the risk of orthostatic hypotension, which is especially dangerous for patients with cardiovascular diseases. The effect of CARECLUB on the ability to drive vehicles and operate complex mechanisms is usually minimal; however, some patients may experience dizziness or drowsiness. If such symptoms appear, one should refrain from driving until full recovery of normal well-being.

Where to buy Careclub in Ukraine

CARECLUB is available for purchase in most pharmacy chains in Ukraine, as well as in specialized online pharmacies that deliver medicines throughout the country. The drug is dispensed by prescription, so before purchasing it is necessary to obtain an appropriate prescription from a qualified specialist. The cost of CARECLUB may vary depending on the region, pharmacy chain, and availability of promotional offers, so patients are recommended to compare prices from several sources. The drug should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius, out of the reach of children.

The shelf life of CARECLUB is three years from the date of manufacture indicated on the package, after which the drug must not be used. Before purchasing CARECLUB, it is important to check the integrity of the packaging and the presence of all necessary markings confirming the authenticity of the product. Patients should purchase medicines only in licensed pharmacy establishments, avoiding questionable sources where counterfeit drugs may be sold. Before starting CARECLUB, it is mandatory to consult a physician, as only a qualified specialist can evaluate the appropriateness of using the drug in a specific clinical case and determine the optimal treatment scheme.